| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/11/2002 | CA2425092A1 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules |
| 04/11/2002 | CA2425072A1 Wt1 fusion polypeptides and methods for wt1 immunotherapy |
| 04/11/2002 | CA2424981A1 Colloidal suspension of submicronic particles for carrying hydrophilic active principles (insulin) and method for preparing same |
| 04/11/2002 | CA2424953A1 Novel human proteases and polynucleotides encoding the same |
| 04/11/2002 | CA2424952A1 Listeria inocua, genome and applications |
| 04/11/2002 | CA2424936A1 Vaccine composition comprising an immunologically active substance embedded in microparticles consisting of starch with reduced molecular weight |
| 04/11/2002 | CA2424931A1 Starch |
| 04/11/2002 | CA2424896A1 A controlled-release, parenterally administrable microparticle preparation |
| 04/11/2002 | CA2424892A1 Biodegradable microparticles for controlled release administration, with purified amylopectin-based starch of reduced molecular weight |
| 04/11/2002 | CA2424888A1 Pharmaceutically acceptable starch |
| 04/11/2002 | CA2424834A1 Nogo receptor homologs |
| 04/11/2002 | CA2424781A1 Methods of isolating bipotent hepatic progenitor cells |
| 04/11/2002 | CA2424761A1 Method of treating cancer using dithiocarbamate derivatives |
| 04/11/2002 | CA2424730A1 Compositions and methods for the transport of biologically active agents across cellular barriers |
| 04/11/2002 | CA2424693A1 Induction of blood vessel formation by polynucleotides encoding sphingosine kinases |
| 04/11/2002 | CA2424668A1 Targeting molecules for adenoviral vectors |
| 04/11/2002 | CA2424604A1 Modulation of the transcription of pro-inflammatory gene products |
| 04/11/2002 | CA2424506A1 Cyclopeptides, a method for their preparation and their use as inhibitors or activators of angiogenesis |
| 04/11/2002 | CA2424285A1 Use of lipopeptides or lipoproteins for the treatment of lung infections and lung tumours |
| 04/11/2002 | CA2424275A1 Haemophilus influenzae antigens and corresponding dna fragments |
| 04/11/2002 | CA2424216A1 Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423656A1 Methods and compositions for enhancing angiogenesis |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423436A1 Methods and compositions for modulating t cell activation and uses thereof |
| 04/11/2002 | CA2422642A1 Human prostate specific g-protein receptor hpraj70 |
| 04/11/2002 | CA2422214A1 Factor vii glycoforms |
| 04/11/2002 | CA2422092A1 Caloxins their isolation and use |
| 04/11/2002 | CA2358860A1 Dna-binding protein yb-1-containing collagen accumulation inhibitors |
| 04/10/2002 | EP1195384A1 Snake proteins having antithrombotic activity |
| 04/10/2002 | EP1195382A2 Testis-specific gene |
| 04/10/2002 | EP1195381A1 Hepatitis c virus epitopes specific for cd4+ t-cell lymphocytes |
| 04/10/2002 | EP1195164A1 Remedies for drug-resistant hypercalcemia |
| 04/10/2002 | EP1195163A1 Serine protease inhibitor |
| 04/10/2002 | EP1194777A1 Methods and compositions relating to pancreatic islet and beta-cell dysfunction |
| 04/10/2002 | EP1194575A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 04/10/2002 | EP1194568A1 Tankyrase homolog protein (thp), nucleic acids, and methods related to the same |
| 04/10/2002 | EP1194560A2 Antigenic neisserial peptides |
| 04/10/2002 | EP1194557A2 An interleukin-1 receptor antagonist and uses thereof |
| 04/10/2002 | EP1194555A1 Methods for making apo-2 ligand using divalent metal ions |
| 04/10/2002 | EP1194554A1 Delivery of trefoil peptides |
| 04/10/2002 | EP1194552A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 04/10/2002 | EP1194550A1 Antimicrobial peptides derived from molluscs |
| 04/10/2002 | EP1194549A2 Human genes and gene expression products |
| 04/10/2002 | EP1194548A1 Novel pyrrhocoricin-derived peptides, and methods of use thereof |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194545A2 Secreted polypeptides and corresponding polynucleotides |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194539A2 Hetero-associating coiled-coil peptides and screening method therefor |
| 04/10/2002 | EP1194534A2 Novel genes encoding proteins having diagnostic, preventive, therapeutic, and other uses |
| 04/10/2002 | EP1194531A2 Cyclic peptidomimetic urokinase receptor antagonists |
| 04/10/2002 | EP1194449A2 Inhibitors of memapsin 2 and use thereof |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194447A2 Novel potassium channels and genes encoding these potassium channels |
| 04/10/2002 | EP1194444A2 Labeled neurotensin derivatives with improved resistance to enzymatic degradation |
| 04/10/2002 | EP1194443A1 Cysteinyl protease inhibitors |
| 04/10/2002 | EP1194439A1 Human eag2 |
| 04/10/2002 | EP1194173A1 X-ray guided drug delivery |
| 04/10/2002 | EP1194172A1 Compositions and methods for the treatment or prevention of autoimmune disorders |
| 04/10/2002 | EP1194170A1 Growth hormone formulations |
| 04/10/2002 | EP1194168A2 Methods and products for manipulating uncoupling protein expression |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194164A1 Prion protein peptides and uses thereof |
| 04/10/2002 | EP1194163A1 Novel methods and medicament for treating infectious diseases involving microbial biofilms |
| 04/10/2002 | EP1194161A1 Stable factor viii compositions |
| 04/10/2002 | EP1194160A1 A somatotropin composition with improved syringeability |
| 04/10/2002 | EP1194159A1 Use of interleukin-6 in treatment of obesity and/or obesity associated disorders |
| 04/10/2002 | EP1194158A2 The use of the protein uk 114 for inhibiting organ transplant rejection |
| 04/10/2002 | EP1194157A1 D-form polypeptide which induces immune tolerance and methods of use |
| 04/10/2002 | EP1194156A1 Method of treating malignancies and viral infections and improving immune function with a dietary supplement |
| 04/10/2002 | EP1194152A1 Src kinase inhibitor compounds |
| 04/10/2002 | EP1194138A1 Nutritional supplements |
| 04/10/2002 | EP1194126A1 Dry powder compositions |
| 04/10/2002 | EP1194123A2 Method for controlled production of ultrafine microparticles and nanoparticles |
| 04/10/2002 | EP1194033A1 Transgenically produced antithrombin iii and mutants thereof |
| 04/10/2002 | EP1178116A9 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 04/10/2002 | EP1161149A4 Ng2/hm proteoglycan-binding peptides that home to angiogenic vasculature and related methods |
| 04/10/2002 | EP1024822B1 Cd8 as an inhibitor of the cellular immune system |
| 04/10/2002 | EP1019077A4 Novel exendin agonist compounds |
| 04/10/2002 | EP0950046B1 3,4-disubstituted azetidin-2-one derivatives useful as cysteine proteinase regulators |
| 04/10/2002 | EP0935458B1 Compositions containing at least one nucleic acid |
| 04/10/2002 | EP0863916B1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/2002 | EP0819009B1 Ovulation triggering drugs comprising luteinising hormone |
| 04/10/2002 | EP0788383B1 Modulation of cell proliferation and wound healing |
| 04/10/2002 | EP0768866B1 Desquamation compositions |
| 04/10/2002 | EP0758900B1 Botulinum toxin FOR REDUCTION OF migraine HEADACHE PAIN |
| 04/10/2002 | EP0752876B1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides |
| 04/10/2002 | EP0694070B1 Recombinant alphavirus vectors |
| 04/10/2002 | EP0675727B1 Glycolipid enzyme-polymer conjugates |
| 04/10/2002 | EP0661990B1 Method for systemic treatment of catabolic conditions and systemic tissue injury |
| 04/10/2002 | EP0607206B1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 04/10/2002 | EP0205555B2 Serine protease inhibitors and methods for isolation of same |
| 04/10/2002 | CN1344322A BASBO55 polynucleotide and polypeptide from neisseria meningitidis uses thereof |
| 04/10/2002 | CN1344321A Screening method |
| 04/10/2002 | CN1344318A Protein for blocking platelet adhesion |
| 04/10/2002 | CN1344315A Improved phytases |
| 04/10/2002 | CN1344287A Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/10/2002 | CN1344275A Methods for amyloid removal using anti-amyloid antibodies |